271 related articles for article (PubMed ID: 18617778)
1. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
[TBL] [Abstract][Full Text] [Related]
2. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
4. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
5. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
6. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of vertebral fractures in adults with cystic fibrosis.
Rossini M; Del Marco A; Dal Santo F; Gatti D; Braggion C; James G; Adami S
Bone; 2004 Sep; 35(3):771-6. PubMed ID: 15336615
[TBL] [Abstract][Full Text] [Related]
8. [Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases].
Miheller P; Tóth M; Molnár E; Zágoni T; Rácz K; Tulassay Z
Orv Hetil; 2001 Jul; 142(29):1557-60. PubMed ID: 11494747
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
10. Vertebral fractures and role of low bone mineral density in Crohn's disease.
Siffledeen JS; Siminoski K; Jen H; Fedorak RN
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):721-8. PubMed ID: 17482522
[TBL] [Abstract][Full Text] [Related]
11. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
12. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
Abildgaard N; Brixen K; Eriksen EF; Kristensen JE; Nielsen JL; Heickendorff L
Haematologica; 2004 May; 89(5):567-77. PubMed ID: 15136220
[TBL] [Abstract][Full Text] [Related]
13. Altered bone metabolism in inflammatory bowel disease.
Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G
Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790
[TBL] [Abstract][Full Text] [Related]
14. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
15. Bone health in children and adolescents after allogeneic stem cell transplantation: high prevalence of vertebral compression fractures.
Taskinen M; Saarinen-Pihkala UM; Hovi L; Vettenranta K; Mäkitie O
Cancer; 2007 Jul; 110(2):442-51. PubMed ID: 17549692
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis.
Shen B; Remzi FH; Oikonomou IK; Lu H; Lashner BA; Hammel JP; Skugor M; Bennett AE; Brzezinski A; Queener E; Fazio VW
Am J Gastroenterol; 2009 Mar; 104(3):639-46. PubMed ID: 19262520
[TBL] [Abstract][Full Text] [Related]
17. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
19. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
Jamal SA; Hayden JA; Beyene J
Am J Kidney Dis; 2007 May; 49(5):674-81. PubMed ID: 17472850
[TBL] [Abstract][Full Text] [Related]
20. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
